- Key geographies covered include the China, India, Brazil and Russia.
- Key segments covered include Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Histology and Cytology, Genetic Testing and Microbiology Culture.
- Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints within IVD market in emerging countries.
- The report also covers information on the leading market players and the competitive landscape.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Transasia Bio-Medicals Ltd. and Beckman Coulter.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the IVD market in emerging countries.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the IVD market in emerging countries? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the IVD market in emerging countries and the factors shaping it.
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 GlobalData Report Guidance 13
3 In Vitro Diagnostics - Device Overview 14
Copyright©2012 PR Newswire.
All rights reserved